Long-Term Follow-up of Humanized and Murine CD19 CAR-T Cell Therapy for B-Cell Malignancies

被引:0
|
作者
Zhang, Yinqiang [1 ,2 ]
Du, Mengyi [1 ,2 ]
Liao, Danying [1 ,2 ]
Xie, Wei [1 ,2 ]
Xiong, Wei [3 ]
Mei, Heng [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan, Peoples R China
[2] Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China
[3] Wuhan Sian Med Technol Co Ltd, Wuhan, Peoples R China
关键词
D O I
10.1182/blood-2023-180440
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Factors Predicting Long-Term Survival Following CD19 CAR T-Cell Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
    Zhang, Xian
    Yang, Junfang
    Li, Wenqian
    Zhang, Gailing
    Su, Yunchao
    Shi, Yanze
    Song, Dan
    Zhang, Min
    He, Jiujiang
    Xu, Li
    Li, Jingjing
    Lu, Xinan
    Li, Jianqiang
    Li, Xiangqun
    Xu, Zhongwei
    Li, Ziyu
    Lu, Peihua
    BLOOD, 2020, 136
  • [42] CD19 CAR-T Cell Therapy: High Efficacy in Autoimmune Diseases
    Brudermanns, Britta
    TRANSFUSIONSMEDIZIN, 2024, 14 (03) : 126 - 126
  • [43] Inflammatory Biomarker Clusters Are Predictive of Response and Toxicity in Large B-Cell Lymphoma Treated with CD19 CAR-T Cell Therapy
    Raj, Sandeep
    Perales, Miguel-Angel
    Fein, Joshua A.
    Tomas, Ana Alarcon
    Batlevi, Connie Lee
    De Lapuerta, Magdalena Corona
    Dahi, Parastoo B.
    Danylesko, Ivetta
    Fried, Shalev
    Funnell, Tyler
    Giralt, Sergio A.
    Jacoby, Elad
    Kedmi, Meirav
    Lin, Richard J.
    Nagler, Arnon
    Nath, Karthik
    Parascondola, Allison
    Palomba, M. Lia
    Salles, Gilles
    Scordo, Michael
    Shah, Gunjan L.
    Shem-Tov, Noga
    Shimoni, Avichai
    Slingerland, John
    Walji, Moneeza
    Yerushalmi, Ronit
    Avigdor, Abraham
    van den Brink, Marcel R. M.
    Shouval, Roni
    BLOOD, 2022, 140
  • [44] CD19 CAR-T cell therapy for relapsed / refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficacies
    Zhang, Li-Na
    Song, Yongping
    Liu, Delong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [45] CD19 CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficacies
    Li-Na Zhang
    Yongping Song
    Delong Liu
    Journal of Hematology & Oncology, 11
  • [46] Preclinical Results of an Allogeneic, Universal CD19/CD7-Targeting CAR-T Cell Therapy (GC502) for B Cell Malignancies
    Ge, Jianning
    Yang, Chunhui
    Sun, Jing
    Chen, Jiao
    Qiu, Shuyi
    Yin, Wenjie
    Shen, Lianjun
    Sersch, Martina
    Cao, Wei
    Wang, Xinxin
    BLOOD, 2021, 138
  • [47] Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CART therapy
    An, Lihong
    Lin, Yuehui
    Deng, Biping
    Yin, Zhichao
    Zhao, Defeng
    Ling, Zhuojun
    Wu, Tong
    Zhao, Yongqiang
    Chang, Alex H.
    Tong, Chunrong
    Liu, Shuangyou
    BMC CANCER, 2022, 22 (01)
  • [48] Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation
    Liu, Shuangyou
    Deng, Biping
    Yin, Zhichao
    Lin, Yuehui
    An, Lihong
    Liu, Dan
    Pan, Jing
    Yu, Xinjian
    Chen, Bingzhen
    Wu, Tong
    Chang, Alex H.
    Tong, Chunrong
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (06) : 671 - 679
  • [49] Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy
    Dahiya, Saurabh
    Luetkens, Tim
    Lutfi, Forat
    Avila, Stephanie
    Iraguha, Thierry
    Margiotta, Philip
    Hankey, Kim G.
    Lesho, Patricia
    Law, Jennie Y.
    Lee, Seung T.
    Baddley, John
    Kocoglu, Mehmet
    Yared, Jean A.
    Hardy, Nancy M.
    Rapoport, Aaron P.
    Atanackovic, Djordje
    BLOOD ADVANCES, 2022, 6 (02) : 686 - 689
  • [50] CD19/CD22 CAR-T Cell Cocktail Therapy Following Autologous Transplantation in Patients with Relapsed/Refractory B-Cell Lymphomas
    Cao, Yang
    Xiao, Yi
    Wang, Na
    Wang, Gaoxiang
    Zhou, Xiaoxi
    Huang, Liang
    Chen, Liting
    Xiao, Min
    Zhang, Tongcun
    Zhang, Yicheng
    Zhou, Jianfeng
    BLOOD, 2020, 136